loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2008_214___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Megafine Pharma (P) Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MEGAFINE PHARMA (P) LIMITED Mumbai IN (1)

    filter

    01 Mirtazapine, Hemihydrate (1)

    filter

    01 India (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    MEGAFINE PHARMA (P) LIMITED Mumbai ...

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • Audit Compliance
    Virtual BoothMegafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Mirtazapine, Hemihydrate

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF CA, AU, BR, MX
    R1-CEP 2008-214 - Rev 03
    Valid
    Chemical
    2023-01-25
    2338
    Megafine Pharma CB

    RDD 2024

    Not Confirmed

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-214 - Rev 03 of Megafine Pharma (p) Limited Mumbai In

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-214 - Rev 03 of Megafine Pharma (p) Limited Mumbai In 1

    20

    Megafine Pharma (p) Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.

    One of their significant offerings is Mirtazapine, Hemihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-214 - Rev 03

    This Chemical Type CEP, issued on January 25, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2338 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY